Publisher
Oto-Rhino-Laryngological Society of Japan, Inc.
Reference42 articles.
1. 1) Chien YC, Chen JY, Liu MY, et al: Serologic Markers of Epstein-Barr Virus Infection and Nasopharyngeal Carcinoma in Taiwanese Men. N Engl J Med 2001; 345: 1877-1882.
2. 2) Yoshizaki T, Kondo S, Wakisaka N, et al: Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma. Cancer Lett 2013; 337: 1-7.
3. 3) Parkin DM, Bray F, Ferlay J, et al: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
4. 4) Yoshizaki T, Wakisaka N, Pagano JS: Chapter 12, Epstein-Barr virus, invasion and metastasis. Epstein-Barr virus, Robertson ES (eds). Caister Academic Press; 2005: pp 171-196.
5. 5) Yoshizaki T, Ito M, Murono S, et al: Current understanding and management of nasopharyngeal carcinoma. Auris Nasus Larynx 2012; 39: 137-144.